Clinical Research Delivery Conference
The Clinical Research Delivery Conference is returning in February 2025
After a successful in-person event in 2023, the Clinical Research Delivery Conference is returning to York.
Aimed at clinical research nurses and other research delivery staff, this event will explore the challenges and opportunities for cancer clinical research and celebrate all those involved in delivering clinical trials. Throughout the day, there will be plenty of opportunities to network, share challenges, and learn best practices.
The programme will include plenary sessions and workshops with a wide range of speakers.
Audience
Research nurses and other patient-facing research delivery roles.
Key information
Wednesday, 26 February 2025
The Principle York
Free event
Our sponsors
We're pleased to have Novocure, Sharp Clinical and Srotas Health sponsoring this year's Clinical Research Delivery Conference.
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialisation of its innovative therapy, Tumour Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. For more information, visit Novocure.com.
Sharp Clinical is a leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing, with a heritage spanning more than 70 years. Their services include formulation development, analytical research, stability studies and sterile manufacturing. Sharp also provides innovative primary packaging solutions, including over-encapsulation, placebo manufacturing, and blister production. They utilise interactive response technology and maintain a global storage and distribution network for various temperature ranges
Srotas Health is an AI-driven health tech company revolutionizing oncology research and clinical trial operations by accelerating patient enrollment and enhancing patient care, ensuring life-saving treatments reach patients more quickly. Its AI-powered platform streamlines patient-trial matching, reducing delays that hinder cancer research and treatment advancements.